So, is there a way you can browse a range of small screen and big screen content for free? Well, keep reading to find out... So, assuming you've ruled out paying a substantial amount for the best ...

The best free games prove that you really don't need a dime to have a good time. With 2025 in full swing, your coffers might be looking sparse after the holiday season. But the good news is that ...

It only takes about 20 minutes a day to rack up enough points to get a free month of Xbox Game Pass and other rewards for using Microsoft's services. Here's how to get a free month of Xbox Game Pass.

Now, those Windsors are positively everywhere. Travelling via dignity-defying minibus to see a play on a Tuesday. (Queen Camilla). At the gym. (Kate, The Princess of Wales). Behind the tills at a ...

We list the best free presentation software, to make it simple and easy to create professional presentations without a subscription to Microsoft PowerPoint. While PowerPoint is the market leader ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.